Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dx Innovations is a molecular diagnostics company based in Salt Lake City, Utah, specializing in the development of ultra-fast nucleic acid amplification and analysis technologies. Founded by Dr. Carl Wittwer, a pioneer in real-time PCR and a co-founder of BioFire Diagnostics, the company is centered on its proprietary "Extreme PCR" and high-speed DNA melting platforms. These innovations aim to reduce PCR cycle times to less than a second, enabling comprehensive diagnostic results in under a minute. Dx Innovations focuses on licensing its intellectual property and collaborating with diagnostic manufacturers to integrate these high-speed capabilities into point-of-care and clinical laboratory systems. The company's technology has been applied to rapid testing for infectious diseases, including COVID-19, and high-resolution genetic analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dx Innovations.